OPHTHOTECH CORPORATION Nonstatutory Stock Option AgreementNonstatutory Stock Option Agreement • March 2nd, 2015 • Ophthotech Corp. • Pharmaceutical preparations • Delaware
OPHTHOTECH CORPORATION Restricted Stock Unit AgreementRestricted Stock Unit Agreement • March 2nd, 2015 • Ophthotech Corp. • Pharmaceutical preparations • Delaware
This Restricted Stock Unit Agreement (this “Agreement”) is made as of the Agreement Date between Ophthotech Corporation (the “Company”), a Delaware corporation, and the Participant.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT NO. 1 TO THE PURCHASE AND SALE AGREEMENTPurchase and Sale Agreement • March 2nd, 2015 • Ophthotech Corp. • Pharmaceutical preparations
This Amendment No. 1 to the Purchase and Sale Agreement (this “Amendment”) is dated as of November 3, 2014 (the “Amendment Effective Date”) by and between Novo A/S, a company organized under the laws of Denmark with offices at Tuborg Havnevej 19, DK-2900 Hellerup, Denmark (“Novo”), and Ophthotech Corporation, a Delaware corporation with offices at One Penn Plaza, Suite 1924, New York, New York 10119 (“Ophthotech”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase and Sale Agreement (the “Agreement”) made effective as of May 23, 2013 (the “Agreement Effective Date”) by and between Novo and Ophthotech. All references to Sections in this Amendment refer to Sections of the Agreement.
